Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Argus Health
Johnson and Johnson
Express Scripts
Farmers Insurance
Boehringer Ingelheim

Generated: April 18, 2019

DrugPatentWatch Database Preview

Litigation Details for Alza Corporation v. Impax Laboratories Inc. (D. Del. 2005)

« Back to Dashboard

Alza Corporation v. Impax Laboratories Inc. (D. Del. 2005)

Small Molecule Drugs cited in Alza Corporation v. Impax Laboratories Inc.

Details for Alza Corporation v. Impax Laboratories Inc. (D. Del. 2005)

Date Filed Document No. Description Snippet Link To Document
2005-09-01 1 Exhibit B following US Patents, owned by Alza Corporation: U.S. Pat. Nos. 4,327,725; 4,612,008; 4,783,337; and 5,082…following US Patents, owned by Alza Corporation: U.S. Pat. Nos. 4,327, 725; 4,612,008; 4,783,337; and 5,082,668…Medical Economics Data (U.S.A.), p. 865-866, (Apr. 4,783,337 A 11/1988 wong et al. ................ 424/468 …United States Patent Lam et al. US006930129B2 US 6,930,129 132 >I=Aug. 16, 2005 (10) Patent N0.: (45…of this J Y patent is extended or adjusted under 35 U.S.C. 154(b) by 113 days. This patent is subject External link to document
2006-12-06 100 part 2 00642-JJF Dooument 100-2 Filed 12/06/2006 US 6,930,129 BZ 11 a decrease in effectiveness during the…00642-JJF Document 100-2 Filed 12/06/2006 ns 6,930,129 132 13 shown in cross-section in FIG. 2. '…Document 100-2 Filed 12/06/2006 Page 3 Of 60 US 6,930,129 BZ 15 No. 967,605, filed Nov. 10, 1997, of which…00642-JJF Document 100-2 Filed 12/06/2006 US 6,930,129 B2 17 18 TABLE 3 -continued Amo¢ligg…00642-JJF Document 100-2 Filed 12/06/2006 US 6.,930,129 BZ 19 continued . 5% cross-linked acrylic External link to document
2006-12-06 101 Redacted Document ownedbyAlzaCorporatinn: U..S l’at. Nos. 4,32‘{, 725; 4,612,008; 4,‘783,337;¢1:¢| 5.0€2,568.“6§ ofvrliichil mmporatedinititentizetybyreferencebereio…described in U.S. Patent Nos. 6,919,3 73 (“the ’373 patent"’) and 6,930,129 (“the ’ 129 patent”) (collectively…treatment methods claimed in the patents in suit. 18. I understand that the patents claim methods of` treating… aa United States Patent nn mem No..- Us 6,919,373 st thm et al. (45) Date of Patent: Jul. 19, 2005 (54…collectively “the patents in suit”). I understand that my opinion will be used in the above-captioned case External link to document
2007-01-05 111 Remark History Vol 1-2, 6,919,373 Prosecution History Vol 1-3 and 6,930,129 Prosecution History Vol 1-2) (dab) (… Patent Histories. Original document(s) on file in Clerk's Office. (1 Box with Prosecution History…September 2005 6 May 2009 1:05-cv-00642-JJF Patent District Court, D. Delaware External link to document
2007-08-20 123 Motion in Limine l T he two patents-in-suit are U.S. Patent Nos. 6,919,373 ("the '373 patent") and 6,…THE FACTS This is a patent infringement case involving two United States Patents directed to unique methods…upon use, would infringe the patents-in-suit. Andrx alleges that the patents-in-suit are invalid and/or…proceedings before the U.S. Patent and Trademark Oftice relating to issuance of the patents. Plaintiffs also intend…4 and 6-7 of the '373 patent and claims l and 4-6 of the '129 patent by the filing of Abbreviated External link to document
2007-08-31 128 Redacted Document rce issued U.S. Patent No. 6,919,373 ("the '373 patent") titled "Meth'ods and Devices… 1-4 and 6-7 of U.S. Pat»ent No. 6,919,373 ("the '373 patent") and claims l Case 1:05-cv…of the '373 patent and claims 1 and 4.-6 of the '129 patent, that the patents are not invalid,…exceptional case. The Patents 4. The patents-in-s-uit are the ‘373 and ’129 patents The application that…States Patent and Trademark Ofi`ice issued U.S. Patent No. 6,930, 129 ("the '129 patent") External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Colorcon
Merck
Mallinckrodt
Deloitte
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.